Pharmaxis to accelerate plans for myelofibrosis combination study after FDA talks- Gary Phillips, CEO, Pharmaxis Ltd 00:00:00
Gary joined the Company in 2003 and was appointed Chief Executive Officer and became a member of the Board of Directors in March 2013. He previously held the positions of Commercial Director and Chief Operating Officer. Gary has more than 30 years of operational management experience in the pharmaceutical and healthcare industry in Europe, Asia and Australia.
